2RZ Stock Forecast - Poseida Therapeutics Inc

	Poseida Therapeutics Inc F:2RZ	US
C	China Southern Airlines Co Ltd F:ZNH	CN
C	Canadian Imperial Bank of Commerce F:CAI	CA
F	Federated Hermes Inc F:3KC	US
	Almonty Industries Inc TSX:AII	CA
M	Mercialys SA F:M8Y	FR
	Controladora Vuela Compania de Aviacion SAB de CV OTC:CTTRF	MX
T	Tilray Brands Inc SWB:2HQ	US
F	Federated Hermes Inc DUS:3KC	US
	Amarin Corporation PLC NASDAQ:AMRN	IE
B	Bank of Communications Co Ltd XMUN:C4C	CN

Wall St Price Targets

There are no price targets for 2RZ.

2RZ Lowest Forecast

2RZ Average Forecast

2RZ Highest Forecast

Central Garden & Pet Co

12% Upside

V

Verkkokauppa.com Oyj

-1% Downside

Central Garden & Pet Co

12% Upside

V

Verkkokauppa.com Oyj

-1% Downside

Revenue
Forecast

67% / Year

Past Growth

13% / Year

Estimated Growth

Estimates Accuracy

32%

Average Beat

67% / Year

Past Growth

13% / Year

Estimated Growth

Estimates Accuracy

32%

Average Beat

Over the last 6 years, the compound annual growth rate for Revenue has been 67%. The projected CAGR for the next 4 years is 13%.

What are analyst estimates?

Gross Profit
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-4%

Average Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-4%

Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Continue 2RZ Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

NASDAQ • USD

PSTX

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

2RZ does not have any price targets made by Wall Street professionals.

Over the last 6 years, the compound annual growth rate for Revenue has been 67%. The projected CAGR for the next 4 years is 13%.

Back to Top

Poseida Therapeutics Inc
F:2RZ

Wall St Price Targets

2RZ Price Targets Summary
Poseida Therapeutics Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue 2RZ Research

What is 2RZ's stock price target?

Not Available

What is the Revenue forecast for Poseida Therapeutics Inc?

Projected CAGR
13%

Company

Help

Tools

Stocks

Poseida Therapeutics Inc F:2RZ

Wall St Price Targets

2RZ Price Targets Summary Poseida Therapeutics Inc

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue 2RZ Research

What is 2RZ's stock price target? Not Available

What is the Revenue forecast for Poseida Therapeutics Inc? Projected CAGR 13%

Company

Help

Tools

Stocks

Poseida Therapeutics Inc
F:2RZ

2RZ Price Targets Summary
Poseida Therapeutics Inc

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is 2RZ's stock price target?

Not Available

What is the Revenue forecast for Poseida Therapeutics Inc?

Projected CAGR
13%